David N. Cook
Chief Tech/Sci/R&D Officer at FORMA THERAPEUTICS HOLDINGS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Shaff | M | 48 | 10 years | |
| Weston Whitaker | M | - |
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | 8 years |
| Stephen T. Isaacs | M | 75 |
X-Biotix Therapeutics, Inc.
 X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | 20 years |
| Ramani Varanasi | F | 54 |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | 8 years |
| Marcus Chapman | M | 53 | 9 years | |
| William DeLoache | M | - |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | 8 years |
| Jeannette Potts | M | 62 | 5 years | |
| Carlo Tanzi | M | - | 9 years | |
| Willard Dere | M | 70 | 7 years | |
| Jennifer Russo Wortman | F | - | 9 years | |
| Ulrich Christian Otte | M | - | 2 years | |
| Gail Schulze | F | 72 | 17 years | |
| Kevin Green | M | 52 | 18 years | |
| Blake Wise | M | 53 |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | 5 years |
| Kurt Graves | M | 56 | 9 years | |
| Richard Kender | M | 68 | 10 years | |
| Thomas DesRosier | M | 69 | 8 years | |
| Dennis Ausiello | M | 78 | 9 years | |
| Thomas Haagen | M | 58 | 2 years | |
| Mitchell Warren | M | - |
Global HIV Vaccine Enterprise
 Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | - |
| Kelly M. Brady | F | - | 6 years | |
| Daniel Janney | M | 58 |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | 4 years |
| Megan Roth | F | - |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | - |
| Nina Russell | M | - |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | - |
| Ruth du Moulin | F | - | 4 years | |
| Ifeyinwa Osunkwo | M | - | 2 years | |
| Helen Boucher | F | - |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | - |
| Michael Pollastri | M | - |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | - |
| Thomas Lodise | M | - |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | - |
| Gérald Voss | M | - |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | - |
| Mark Feinberg | M | - |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | - |
| Howard Njoo | M | - |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | - |
| Lynn Morris | M | - |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | - |
| Nelson Michael | M | - |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | - |
| Carl Dieffenbach | M | - |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | - |
| Barbara McGovern | M | - | 9 years | |
| Yves Lévy | M | - |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | - |
| Kiersten Stead | M | - |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | 4 years |
| Nina Mufti | M | - | 17 years | |
| Zachary Hornby | M | 45 |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | 3 years |
| Purnima Mane | M | - |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 12 years |
| Todd Shegog | M | 59 | 5 years | |
| Mary Wadlinger | F | 64 | 10 years | |
| Christopher D. Ray | M | 54 |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | - |
| Mario Corso | M | - | 4 years | |
| Michael Bonney | M | 65 |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | 4 years |
| Steve Benz | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael A. Foley | M | 62 | 9 years | |
| Roger Pomerantz | M | 67 | 6 years | |
| Margaret McGlynn | F | 64 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 4 years |
| David Berry | M | 47 | 5 years | |
| Frank Lee | M | 56 | 3 years | |
| Steve Hall | M | 69 | 11 years | |
| Peter Kolchinsky | M | 47 | 3 years | |
| Grégory Behar | M | 55 | 9 years | |
| Patrick F. Kelly | M | 60 | 6 years | |
| Lorence Kim | M | 49 | 6 years | |
| John G. Aunins | M | 63 | 8 years | |
| Meryl Zausner | F | 67 | 5 years | |
| Melinda Moree | M | - |
Bio Ventures for Global Health
| 3 years |
| Michal Silverberg | F | 48 | 3 years | |
| Selwyn Vickers | M | 64 | 1 years | |
| Wayne Frederick | M | 52 | 2 years | |
| Timothy Bruce Anderson | M | 77 | 18 years | |
| Paolo Augusto Paoletti | M | 73 | 6 years | |
| Peter Wirth | M | 73 | 10 years | |
| Marsha Fanucci | F | 70 | 8 years | |
| Timothy Clackson | M | 58 | 4 years | |
| Thomas Wiggans | M | 72 | 2 years | |
| Werner Cautreels | M | 71 | 3 years | |
| John E. Hearst | M | - | 12 years | |
| Peter Hutt | M | 89 | 4 years | |
| Claes Glassell | M | 73 | 7 years | |
| Bruce Cozadd | M | 60 | 17 years | |
| William R. Rohn | M | 80 | 9 years | |
| Arturo Molina | M | 65 | - | |
| James J. Vaughn | M | 61 | 4 years | |
| Alice P. Albright | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
| Jeff York | M | - | 8 years | |
| Jennifer Lachey | M | 51 | 1 years | |
| Michele Trucksis | M | 71 | 3 years | |
| Jim Weston | M | - | - | |
| Mohamed Wa’el Ahmed Hashad | M | 61 | 1 years | |
| Adel Mahmoud | M | 82 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
| Mary Tydings | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
| Kevin J. Horgan | M | 64 | - | |
| Cynthia A. Hallenbeck | F | 67 |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | 3 years |
| Michael Caulfield | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 2 years |
| Dirk Brockstedt | M | 55 | 5 years | |
| Michel Gréco | M | 80 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 9 years |
| Thomas Dubensky | M | 66 | 5 years | |
| Sylvia R. Wheeler | F | 63 | 3 years | |
| C. Larkin | M | 75 | - | |
| Jim Connolly | M | 59 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 2 years |
| William Dawson | M | 69 | 5 years | |
| Gregory W. Schafer | M | 59 | 7 years | |
| John Bishop | M | 62 | 2 years | |
| Kapil Sibal | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 98 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David N. Cook
- Personal Network
